Pristinamycin

From WikiMD's Wellnesspedia

Pristinamycin is a streptogramin antibiotic produced by the bacterium Streptomyces pristinaespiralis. It is a combination of two chemically distinct components, pristinamycin IA (a macrolide) and pristinamycin IIA (a streptogramin B), which work synergistically to inhibit bacterial protein synthesis. This antibiotic is particularly effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus spp. Pristinamycin is used primarily in France and some other European countries to treat various bacterial infections, including skin infections, respiratory tract infections, and bone and joint infections.

Mechanism of Action[edit | edit source]

Pristinamycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Pristinamycin IA interferes with the formation of the initiation complex and peptide bond formation, while pristinamycin IIA binds to a different site on the 50S subunit to prevent elongation of the protein chain. The dual action of pristinamycin IA and IIA results in a bactericidal effect against susceptible bacteria.

Pharmacokinetics[edit | edit source]

The pharmacokinetics of pristinamycin are characterized by its oral bioavailability and distribution in various tissues, including bone. It is metabolized in the liver and excreted primarily in the bile and, to a lesser extent, in the urine. The half-life of pristinamycin allows for twice-daily dosing in most therapeutic indications.

Clinical Uses[edit | edit source]

Pristinamycin is indicated for the treatment of various infections caused by susceptible strains of bacteria. These include:

  • Skin and soft tissue infections (e.g., cellulitis, erysipelas)
  • Respiratory tract infections (e.g., sinusitis, pharyngitis, bronchitis)
  • Bone and joint infections
  • Dental infections

Due to its effectiveness against MRSA, pristinamycin is an important option in areas with high rates of antibiotic resistance.

Side Effects[edit | edit source]

The most common side effects of pristinamycin include gastrointestinal disturbances (nausea, vomiting, diarrhea), rash, and allergic reactions. Hepatotoxicity and hematological changes have been reported but are rare.

Resistance[edit | edit source]

Bacterial resistance to pristinamycin can occur through various mechanisms, including modification of the antibiotic target sites, enzymatic inactivation, and efflux pumps. Continuous monitoring of resistance patterns is essential for the effective use of pristinamycin in clinical practice.

Conclusion[edit | edit source]

Pristinamycin is a valuable antibiotic for the treatment of infections caused by Gram-positive bacteria, including MRSA. Its unique mechanism of action and synergistic components make it an important option in the management of antibiotic-resistant infections. However, like all antibiotics, prudent use is essential to minimize the development of resistance.

Resources[edit source]

Latest articles - Pristinamycin

PubMed
Clinical trials
UpToDate

AI tools[edit source]

Generative AI tools and links to learn more on Pristinamycin: ChatGPT - Bing Chat - Google Gemini. (caution advised).


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD